TFF Pharmaceuticals, Inc. - Common Stock (TFFP)
0.0650
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 7th, 5:00 AM EDT
Detailed Quote
Previous Close | 0.0650 |
---|---|
Open | - |
Bid | 0.1320 |
Ask | 0.1368 |
Day's Range | N/A - N/A |
52 Week Range | 0.0650 - 4.612 |
Volume | 0 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | - |
Chart
About TFF Pharmaceuticals, Inc. - Common Stock (TFFP)
Tff Pharmaceuticals Inc is a biotechnology company focused on developing innovative drug delivery systems and therapies utilizing its proprietary thin film freezing technology. This advanced platform enables the formulation of a wide range of drugs, enhancing their solubility and bioavailability, ultimately aiming to improve patient outcomes. The company's research efforts are centered on addressing unmet medical needs across various therapeutic areas, including respiratory diseases and oncology, by offering safer and more effective treatment options. Tff Pharmaceuticals is committed to advancing pharmaceutical technologies while collaborating with partners to bring transformative therapies to market. Read More
News & Press Releases

Via Benzinga · December 12, 2024

Via Benzinga · December 12, 2024

Via Benzinga · December 11, 2024

Via Benzinga · December 11, 2024

Via Benzinga · December 11, 2024

Via Benzinga · November 19, 2024

Via Benzinga · November 19, 2024

Via Benzinga · November 15, 2024

Via Benzinga · November 15, 2024

Via Benzinga · November 15, 2024

Via Benzinga · November 15, 2024

Via Benzinga · October 30, 2024

Via Benzinga · October 25, 2024

TFFP stock results show that TFF Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 14, 2024

52-week-low losers may be your ticket to finding excellent stocks to buy. Take a look at these three buy-rated (potential) winners.
Via InvestorPlace · June 19, 2024

Via Benzinga · May 16, 2024

TFFP stock results show that TFF Pharmaceuticals missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 14, 2024

TFFP stock results show that TFF Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 28, 2024

Via Benzinga · March 27, 2024

TFFP stock results show that TFF Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2023.
Via InvestorPlace · December 20, 2023

TFFP stock results show that TFF Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2023.
Via InvestorPlace · December 20, 2023

TFFP stock results show that TFF Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2023.
Via InvestorPlace · December 20, 2023